Published in Croat Med J on August 01, 2012
4-hydroxynonenal-mediated signaling and aging. Free Radic Biol Med (2016) 0.75
Dihydropyridine Derivatives as Cell Growth Modulators In Vitro. Oxid Med Cell Longev (2017) 0.75
Signaling by 4-hydroxy-2-nonenal: Exposure protocols, target selectivity and degradation. Arch Biochem Biophys (2016) 0.75
Short overview on metabolomics approach to study pathophysiology of oxidative stress in cancer. Redox Biol (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
The hallmarks of cancer. Cell (2000) 113.05
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med (1991) 16.01
Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res (2004) 7.50
Protein oxidation in aging, disease, and oxidative stress. J Biol Chem (1997) 7.35
Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer (2005) 6.46
Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta (2003) 4.78
Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature (2000) 4.62
Persistent oxidative stress in cancer. FEBS Lett (1995) 3.85
Oxidative DNA damage and disease: induction, repair and significance. Mutat Res (2004) 3.54
8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev (2009) 3.46
Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res (2011) 2.54
Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett (2008) 2.27
Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine. J Intern Med (2012) 2.13
Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem (2008) 2.09
Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst (2001) 2.04
Pathological aspects of lipid peroxidation. Free Radic Res (2010) 1.56
4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med (2003) 1.49
Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns. Carcinogenesis (2007) 1.48
Error prone translesion synthesis past gamma-hydroxypropano deoxyguanosine, the primary acrolein-derived adduct in mammalian cells. J Biol Chem (2002) 1.46
Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases. Proc Natl Acad Sci U S A (2000) 1.44
Chemistry and biology of DNA containing 1,N(2)-deoxyguanosine adducts of the alpha,beta-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chem Res Toxicol (2009) 1.38
Role of reactive oxygen species in skin carcinogenesis. Antioxid Redox Signal (2004) 1.38
Targeted therapies: how personal should we go? Nat Rev Clin Oncol (2011) 1.31
The presence of 5-hydroxymethylcytosine at the gene promoter and not in the gene body negatively regulates gene expression. Biochem Biophys Res Commun (2011) 1.12
Protein carbonylation. Antioxid Redox Signal (2010) 1.11
Advances in methods for the determination of biologically relevant lipid peroxidation products. Free Radic Res (2010) 1.02
Feedback within the inter-cellular communication and tumorigenesis in carcinomas. PLoS One (2012) 0.95
DNA cross-link induced by trans-4-hydroxynonenal. Environ Mol Mutagen (2010) 0.90
The involvement of granulocytes in spontaneous regression of Walker 256 carcinoma. Cancer Lett (2008) 0.87
The influence of 4-hydroxy-2-nonenal on proliferation, differentiation and apoptosis of human osteosarcoma cells. Biofactors (2005) 0.86
Oxidative burst of neutrophils against melanoma B16-F10. Cancer Lett (2006) 0.85
c-Jun N-terminal kinase upregulation as a key event in the proapoptotic interaction between transforming growth factor-beta1 and 4-hydroxynonenal in colon mucosa. Free Radic Biol Med (2006) 0.85
Oxidative burst and anticancer activities of rat neutrophils. Biofactors (2005) 0.84
Nickel-induced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation. J Biol Chem (2012) 0.83
Tissue distribution of lipid peroxidation product acrolein in human colon carcinogenesis. Free Radic Res (2006) 0.83
Differential sensitivity to 4-hydroxynonenal for normal and malignant mesenchymal cells. Redox Rep (2007) 0.83
Granulocytes as effective anticancer agent in experimental solid tumor models. Immunobiology (2010) 0.82
Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression. Clin Exp Immunol (2012) 0.80
Induction of CMV-1 promoter by 4-hydroxy-2-nonenal in human embryonic kidney cells. Acta Biochim Pol (2010) 0.78
Lipid peroxidation product acrolein as a predictive biomarker of prostate carcinoma relapse after radical surgery. Free Radic Res (2010) 0.78
HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats. Free Radic Res (2010) 0.78
Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis (2008) 1.13
Gastric cancer: the role of insulin-like growth factor 2 (IGF 2) and its receptors (IGF 1R and M6-P/IGF 2R). J Pathol (2003) 0.98
Anticancer and antioxidative effects of micronized zeolite clinoptilolite. Anticancer Res (2003) 0.98
Effect of indomethacin on E-cadherin and beta-catenin expression in HT-29 colon cancer cells. Exp Mol Pathol (2005) 0.96
Oxidative stress in small-for-gestational age (SGA) term newborns and their mothers. Free Radic Res (2009) 0.96
Association of MTHFR, MTR, MTRR, RFC1, and DHFR gene polymorphisms with susceptibility to sporadic colon cancer. DNA Cell Biol (2011) 0.95
Comparative study on the antioxidant and biological activities of carvacrol, thymol, and eugenol derivatives. J Agric Food Chem (2008) 0.92
Natural and synthetic antioxidants: an updated overview. Free Radic Res (2010) 0.91
The influence of isorel on the advanced colorectal cancer. Cancer Biother Radiopharm (2003) 0.88
Pathophysiological relevance of aldehydic protein modifications. J Proteomics (2013) 0.87
The influence of 4-hydroxy-2-nonenal on proliferation, differentiation and apoptosis of human osteosarcoma cells. Biofactors (2005) 0.86
IL-2 -330 T/G SNP and serum values-potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs). J Mol Med (Berl) (2010) 0.85
The association between proinflammatory cytokine polymorphisms and cerebral palsy in very preterm infants. Cytokine (2012) 0.85
An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's disease. J Pathol (2009) 0.85
TNF alpha promoter polymorphisms analysis in benign and malignant breast lesions. Exp Mol Pathol (2007) 0.84
Interval hypoxic training in complex treatment of Helicobacter pylori-associated peptic ulcer disease. Acta Biochim Pol (2010) 0.84
Reversal of multidrug resistance in murine lymphoma cells by amphiphilic dihydropyridine antioxidant derivative. Anticancer Res (2010) 0.84
Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions. Mutat Res (2006) 0.84
Differential sensitivity to 4-hydroxynonenal for normal and malignant mesenchymal cells. Redox Rep (2007) 0.83
K-ras and Dpc4 mutations in chronic pancreatitis: case series. Croat Med J (2007) 0.83
Cyp4a14 overexpression induced by hyperoxia in female CBA mice as a possible contributor of increased resistance to oxidative stress. Free Radic Res (2010) 0.82
Effect of angiotensin II on inflammation pathways in human primary bone cell cultures in otosclerosis. Audiol Neurootol (2012) 0.81
Distribution of 4-hydroxynonenal-protein conjugates as a marker of lipid peroxidation and parameter of malignancy in astrocytic and ependymal tumors of the brain. Tumori (2010) 0.81
IL-6-174 C/G polymorphism in the gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Exp Mol Pathol (2007) 0.81
TNF-alpha promoter single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine tumors. Neuroendocrinology (2006) 0.81
Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis. Cancer Lett (2009) 0.81
Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation. Mutat Res (2004) 0.80
Lipid peroxidation product 4-hydroxynonenal as factor of oxidative homeostasis supporting bone regeneration with bioactive glasses. Acta Biochim Pol (2010) 0.80
Alterations of FHIT and P53 genes in keratocystic odontogenic tumor, dentigerous and radicular cyst. J Oral Pathol Med (2008) 0.79
Decrease in circulating DNA, IL-10 and BAFF levels in newly-diagnosed SLE patients after corticosteroid and chloroquine treatment. Cell Immunol (2012) 0.79
Double-edged sword behaviour of gallic acid and its interaction with peroxidases in human microvascular endothelial cell culture (HMEC-1). Antioxidant and pro-oxidant effects. Acta Biochim Pol (2010) 0.79
Endogenous 4-hydroxy-2-nonenal in microalga Chlorella kessleri acts as a bioactive indicator of pollution with common herbicides and growth regulating factor of hormesis. Aquat Toxicol (2011) 0.78
Interleukin 1β gene single-nucleotide polymorphisms and susceptibility to pancreatic neuroendocrine tumors. DNA Cell Biol (2011) 0.78
Induction of CMV-1 promoter by 4-hydroxy-2-nonenal in human embryonic kidney cells. Acta Biochim Pol (2010) 0.78
HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats. Free Radic Res (2010) 0.78
Loss of NF2/Merlin expression in advanced sporadic colorectal cancer. Cell Oncol (Dordr) (2013) 0.78
Lipid peroxidation product acrolein as a predictive biomarker of prostate carcinoma relapse after radical surgery. Free Radic Res (2010) 0.78
Growth modulation of human cells in vitro by mild oxidative stress and 1,4-dihydropyridine derivative antioxidants. Coll Antropol (2011) 0.77
Stobadine attenuates impairment of an intestinal barrier model caused by 4-hydroxynonenal. Toxicol In Vitro (2012) 0.77
Bioactive 1,4-dihydroisonicotinic acid derivatives prevent oxidative damage of liver cells. Eur J Pharmacol (2006) 0.77
Loss of heterozygosity testing using real-time PCR analysis of single nucleotide polymorphisms. J Cancer Res Clin Oncol (2005) 0.77
Association of TNF promoter polymorphisms with type 1 diabetes in the South Croatian population. Biol Res (2008) 0.77
Ergometry induces systemic oxidative stress in healthy human subjects. Tohoku J Exp Med (2010) 0.77
P2RY12 gene polymorphisms and effect of clopidogrel on platelet aggregation. Coll Antropol (2013) 0.77
Effects of bioreactive acrolein from automotive exhaust gases on human cells in vitro. Environ Toxicol (2011) 0.77
New insights into the role of chronic inflammation and cytokines in the etiopathogenesis of gastroenteropancreatic neuroendocrine tumors. Neuroendocrinology (2014) 0.77
APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia. Exp Mol Pathol (2004) 0.76
Interleukin-6-174 G/C polymorphism is not associated with IL-6 expression and susceptibility to sporadic colon cancer. DNA Cell Biol (2010) 0.76
In reply. Int J Gynecol Pathol (2013) 0.75
Genetic evaluation of the TNF-α -238G>A and -308G>A promoter polymorphisms in Croatian patients with type I diabetes. Hum Immunol (2010) 0.75
Infrequent alteration of the DPC4 tumor suppressor gene in renal cell carcinoma. Urol Res (2004) 0.75